Hot search: Management  Alcohol  super  industrial  nut  Financial 
 
Home > News > Market > Content

New Therapy to Eradicate H. Pylori Be Launched by Pernix

increase font size  reduce font Add date: 2016-11-30  Hits:72
Core prompt: Pernix Therapeutics Holdings has launched Omeclamox-Pak, a ten-day therapy, to eradicate Helicobacter pylori (H. pylori) in adult patien

Pernix Therapeutics Holdings has launched Omeclamox-Pak, a ten-day therapy, to eradicate Helicobacter pylori (H. pylori) in adult patients.

Omeclamox-Pak is composed of omeprazole delayed-release capsules (20mg), clarithromycin tablets (500mg) and amoxicillin capsules (500mg) for the treatment of H. pylori infection and duodenal ulcer disease.

Pernix sales and marketing vice president Chuck Hrushka said the company recruited a new sales force and established a targeted marketing program that will reach gastroenterology professionals in the coming months.

"We anticipate physicians and their patients will welcome the short, 10-day dosing regimen, especially when compared to other treatments," Hrushka added.

The triple combination medication which is taken orally consists of the protein pump inhibitor omeprazole and two broad spectrum antibiotics; clarithromycin tablets and amoxicillin capsules.

 

 
 
[ NewsSearch ]  [ Send Fav ]  [ Share ]  [ Print ]  [ Send Report ]  [ Close ]

 
Total0bar [View All]  Related Comments

 
Photo Recommended
Recommend News
Click Rank
 
Home | Products | Suppliers | News | Tradeshow | Sitemap | Message | RSS Feed